GO:0071409 cellular response to cycloheximide: Protein Synthesis Stress Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071409 cellular response to cycloheximide describes how a cell changes its state or activity after exposure to cycloheximide, an antibiotic that blocks eukaryotic protein synthesis.
• Cycloheximide triggers stress-responsive signaling, including phosphorylation of eIF2alpha and activation of NF-kappaB, linking translation inhibition to gene expression programs.
• The response intersects with cell-cycle control, as inhibition of protein synthesis alters cyclin B accumulation and growth in mammalian cells.
• Cycloheximide is widely used experimentally as a translation inhibitor to test whether a process depends on new protein synthesis.
• Studying GO:0071409 helps reveal how cells sense and adapt to translational stress, with relevance to cancer, aneuploidy, and ribosome-related disorders.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes in the cycloheximide response.
Description
GO:0071409 cellular response to cycloheximide is a Gene Ontology biological process term that captures any change in a cell's state or activity in response to cycloheximide, an antibiotic produced by some Streptomyces species that interferes with protein synthesis in eukaryotes. Because cycloheximide rapidly inhibits translation elongation, cells mount a coordinated response that includes stress signaling, changes in gene expression, and cell-cycle adjustments. This term is therefore central to experiments that use cycloheximide as a tool to probe translational control and stress adaptation. Researchers studying this response aim to identify the signaling pathways, transcription factors, and effector proteins that mediate cellular adaptation to translation inhibition. The response is not merely a passive shutdown; it involves active signaling such as eIF2alpha phosphorylation and NF-kappaB activation, which can reshape the transcriptome and proteome. Understanding GO:0071409 also has broader implications because translation stress pathways are implicated in cancer, aneuploidy, and other disease states.
cellular response to cycloheximide At A Glance
| GO ID | GO:0071409 |
|---|---|
| GO term | cellular response to cycloheximide |
| Ontology | biological_process |
| Synonym | cellular response to actidione |
| Definition | Any process that results in a change in state or activity of a cell as a result of a cycloheximide stimulus; cycloheximide is an antibiotic that interferes with eukaryotic protein synthesis. |
| Major function | Cellular adaptation to translation inhibition, including stress signaling and gene expression changes. |
| Related processes | eIF2alpha phosphorylation, NF-kappaB activation, cell-cycle regulation, protein synthesis control. |
| Key experimental use | Cycloheximide is used to block new protein synthesis and test dependency of cellular processes on translation. |
| Disease relevance | Translation stress pathways are linked to cancer, aneuploidy, and ribosome-related disorders. |
What Is GO:0071409?
In our own words, GO:0071409 cellular response to cycloheximide refers to the collection of cellular processes triggered when a cell encounters cycloheximide. Cycloheximide is an antibiotic that blocks protein synthesis in eukaryotes, so the cell responds by altering signaling, gene expression, secretion, movement, or other activities. This term encompasses the immediate and downstream molecular events that allow the cell to sense and react to this translational stress.
Why Is cellular response to cycloheximide Important in Cell Biology?
GO:0071409 is important because cycloheximide is one of the most widely used experimental tools to inhibit translation, and understanding how cells respond to it reveals fundamental mechanisms of translational control and stress adaptation. This response connects directly to signaling pathways that regulate cell growth, survival, and gene expression, making it relevant to cancer biology, aneuploidy, and other disease contexts.
• Cycloheximide is a standard reagent for testing whether a cellular process requires new protein synthesis.
• The response involves eIF2alpha phosphorylation, a conserved translation-initiation control mechanism.
• NF-kappaB activation in response to cycloheximide links translation stress to inflammatory and survival signaling.
• Cycloheximide alters cyclin B accumulation and cell-cycle progression, connecting translation to proliferation control.
• Studying this response helps interpret experiments using translation inhibitors in cancer and stem cell research.
• Aneuploid cells show altered stress responses, and cycloheximide sensitivity can reveal proteotoxic vulnerabilities.
• The term supports research on ribosome quality control and integrated stress response pathways.
• It provides a framework for understanding how cells prioritize gene expression under translational stress.
What Happens During cellular response to cycloheximide?
Immediate translation inhibition
In simple terms: Cycloheximide quickly stops the cell's protein factories from making new proteins.
Cycloheximide interferes with protein synthesis in eukaryotes, leading to rapid inhibition of translation elongation. This immediate block on new protein production is the initiating stimulus for the cellular response.
Stress signaling and eIF2alpha phosphorylation
In simple terms: The cell turns on stress alarms when protein production is blocked.
Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eIF2alpha) is required for activation of NF-kappaB in response to diverse cellular stresses, including translation inhibition. This phosphorylation event is a key node in the cellular response to cycloheximide.
NF-kappaB activation and gene expression changes
In simple terms: The cell activates transcription factors that change which genes are turned on or off.
Cycloheximide-induced stress leads to NF-kappaB activation, which can drive changes in gene expression as part of the cellular response. This transcriptional response helps the cell adapt to translation inhibition.
Cell-cycle and growth adjustments
In simple terms: Blocking protein synthesis can slow or alter how cells grow and divide.
Inhibition of protein synthesis by cycloheximide affects cyclin B accumulation and cellular growth, linking the response to cell-cycle regulation. Different cell lines can show distinct regulation of protein synthesis and growth under these conditions.
Proteome and stress-response remodeling
In simple terms: The cell reshapes its protein landscape to cope with the block.
The cellular response to cycloheximide involves changes in the synthesis and accumulation of specific proteins, including stress-related factors. This remodeling can influence survival, proliferation, and sensitivity to further stress.
Key Genes Involved in GO:0071409 cellular response to cycloheximide
The following genes and proteins are central to the cellular response to cycloheximide, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF2S1 | Encodes eIF2alpha; phosphorylation required for NF-kappaB activation under stress | Key node in translation stress signaling |
| NFKB1 | NF-kappaB subunit activated downstream of eIF2alpha phosphorylation | Links translation stress to inflammatory gene expression |
| NFKB2 | NF-kappaB subunit contributing to stress-responsive transcription | Part of NF-kappaB activation in stress responses |
| RELA | NF-kappaB transcription factor regulating stress and survival genes | Mediates gene expression changes in response to stress |
| CCNB1 | Cyclin B; accumulation affected by protein synthesis inhibition | Connects translation inhibition to cell-cycle control |
| CDK1 | Cyclin-dependent kinase 1; partner of cyclin B in mitosis | Cell-cycle regulation under translation stress |
| TP53 | Tumor suppressor; p53-dependent responses to cellular stress | May modulate cell fate under translation inhibition |
| CDKN1A | p21; cell-cycle inhibitor regulated by p53 and Rb under stress | Potential effector of growth arrest in stress responses |
| RB1 | Retinoblastoma protein; regulates p21 in oxidative stress responses | Links cell-cycle control to stress signaling |
| HMGCR | Mevalonate pathway enzyme; isoprenylation altered by mevalonate availability | Shows metabolic modulation of protein modifications |
| RAP1A | Small GTPase subject to isoprenylation; affected by mevalonate availability | Example of post-translational modification sensitive to cellular state |
| RAB proteins | Family of GTPases requiring isoprenylation for membrane localization | Isoprenylation changes can affect trafficking under stress |
| RAS proteins | GTPases with isoprenylation-dependent function | Mevalonate availability alters isoprenylation of cellular proteins |
| GR (NR3C1) | Glucocorticoid receptor; expression regulated by cAMP | Example of hormone-responsive gene expression |
| ESR1 | Estrogen receptor; early changes in cellular subpopulations after estradiol | Model for receptor dynamics in response to stimuli |
| CDC2 | Cell division cycle 2; related to cyclin B/CDK1 regulation | Cell-cycle control under translation inhibition |
| ANEUPLOIDY-RELATED GENES | Genes affecting chromosome segregation and stress sensitivity | Aneuploid cells show altered stress responses |
How Is cellular response to cycloheximide Regulated?
The cellular response to cycloheximide is regulated at multiple levels. Phosphorylation of eIF2alpha is a key regulatory event that controls translation initiation and is required for NF-kappaB activation under diverse stresses. Cell-cycle regulators such as cyclin B and CDK1 are also modulated when protein synthesis is inhibited, affecting growth and division. Additionally, post-translational modifications like isoprenylation can be influenced by metabolic availability, indirectly shaping cellular responses. These layers of regulation ensure that the cell can adapt its gene expression and growth programs under translation stress.
cellular response to cycloheximide and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF2S1 | Translation stress, inflammatory signaling | Knock-in of phospho-mutant eIF2alpha |
| NFKB1 | Inflammation, cancer | Knockout in cancer cell lines |
| CCNB1 | Cell-cycle dysregulation, cancer | Overexpression and knockout models |
| TP53 | Cancer, stress response | Point mutation knock-in |
| CDKN1A | Cell-cycle arrest, cancer | Knockout and reporter knock-in |
Cancer and aneuploidy
Aneuploidy, a hallmark of many cancers, alters cellular stress responses and can affect sensitivity to translation inhibitors. The cellular response to cycloheximide intersects with pathways that control proliferation and survival, making it relevant to cancer research.
Translation stress and inflammatory signaling
eIF2alpha phosphorylation and NF-kappaB activation link translation stress to inflammatory and immune signaling. Dysregulation of these pathways is implicated in chronic inflammation and cancer.
Cell-cycle and growth disorders
Cycloheximide-induced changes in cyclin B accumulation and cell growth connect the response to cell-cycle control. Defects in these processes can contribute to developmental and proliferative disorders.
Metabolic and post-translational modification disorders
Altered isoprenylation of cellular proteins in response to mevalonate availability shows how metabolic states can influence protein function. This has implications for diseases linked to lipid metabolism and protein prenylation.
From cellular response to cycloheximide-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate cycloheximide-induced NF-kappaB activation? | Knockout of gene X in HEK293 or HeLa cells |
| Does phosphorylation of eIF2alpha at Ser51 control the response? | Point mutation knock-in of EIF2S1 S51A |
| Does gene Y affect cyclin B accumulation under translation inhibition? | Overexpression and knockout of gene Y |
| Is protein Z required for cell survival under cycloheximide? | CRISPR knockout followed by viability assays |
| Does a disease-associated mutation alter stress sensitivity? | Knock-in of the patient mutation |
| Can a tagged protein report translation stress in real time? | Tagged knock-in of a stress reporter |
How to Study the cellular response to cycloheximide Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Genome-wide translation efficiency | Identify mRNAs translated under cycloheximide stress |
| RNA-seq | Transcriptome changes | Discover stress-responsive gene expression programs |
| Phosphoproteomics | Phosphorylation events | Detect eIF2alpha and NF-kappaB pathway activation |
| Western blot | Protein levels and modifications | Validate eIF2alpha phosphorylation and cyclin B levels |
| Luciferase reporter | NF-kappaB transcriptional activity | Measure stress-induced NF-kappaB activation |
| Flow cytometry | Cell-cycle distribution | Assess cyclin B and growth changes |
| Immunofluorescence | Protein localization | Visualize NF-kappaB nuclear translocation |
| CRISPR screening | Gene requirement | Identify genes essential for the cycloheximide response |
Ribosome profiling (Ribo-seq)
Ribo-seq measures genome-wide translation by sequencing ribosome-protected mRNA fragments. It can reveal how cycloheximide treatment changes translation efficiency and which mRNAs are preferentially translated under stress.
RNA sequencing (RNA-seq)
RNA-seq quantifies changes in gene expression after cycloheximide exposure, identifying transcriptional programs activated by translation stress.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can detect changes in protein abundance and phosphorylation, such as eIF2alpha phosphorylation, in response to cycloheximide.
Imaging and reporter assays
Fluorescent reporters and live-cell imaging can track translation inhibition, NF-kappaB nuclear translocation, and cell-cycle progression in real time.
How CRISPR Can Be Used to Study GO:0071409 cellular response to cycloheximide
Knockout
CRISPR knockout of candidate genes such as EIF2S1, NFKB1, or CCNB1 can test their requirement for the cellular response to cycloheximide. Knockout cell lines are valuable for loss-of-function studies in stress signaling.
Point Mutation
Point mutation knock-in, such as EIF2S1 S51A, can dissect the role of specific phosphorylation sites in the response. This approach provides precise mechanistic insights beyond simple knockout.
Knock-in
Knock-in of tagged or reporter genes allows real-time monitoring of stress pathway activation and protein dynamics under cycloheximide treatment. This is useful for imaging and biochemical assays.
Overexpression
Overexpression of genes like CCNB1 or NFKB1 can test sufficiency in driving or modulating the cycloheximide response. Overexpression models complement knockout studies to establish causality.
How EDITGENE Supports cellular response to cycloheximide Research
Researchers studying cellular response to cycloheximide-related genes often need to determine whether a candidate gene is causally involved in stress signaling, translation control, or cell-cycle regulation. EDITGENE provides the CRISPR tools and services to build precisely engineered cell models for such mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for cellular response to cycloheximide research.
Frequently Asked Questions About cellular response to cycloheximide
What is GO:0071409 cellular response to cycloheximide?
GO:0071409 is a Gene Ontology biological process term describing any change in a cell's state or activity in response to cycloheximide, an antibiotic that inhibits eukaryotic protein synthesis.
What does cycloheximide do to cells?
Cycloheximide interferes with protein synthesis in eukaryotes, leading to rapid translation inhibition and activation of stress signaling pathways.
What genes are involved in the cellular response to cycloheximide?
Key genes include EIF2S1 (eIF2alpha), NFKB1, RELA, CCNB1, and CDK1, which mediate stress signaling and cell-cycle adjustments.
How is eIF2alpha involved in the response to cycloheximide?
Phosphorylation of eIF2alpha is required for NF-kappaB activation in response to diverse stresses, including translation inhibition.
Why do researchers use cycloheximide in experiments?
Cycloheximide is used to block new protein synthesis and test whether a cellular process depends on translation.
Does cycloheximide affect the cell cycle?
Yes, inhibition of protein synthesis by cycloheximide alters cyclin B accumulation and cellular growth, affecting cell-cycle progression.
What diseases are linked to translation stress responses?
Translation stress pathways are implicated in cancer, aneuploidy, and inflammatory signaling.
How can CRISPR be used to study the cycloheximide response?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in the response.
What methods are used to study cellular response to cycloheximide?
Common methods include Ribo-seq, RNA-seq, phosphoproteomics, Western blot, and imaging-based reporter assays.
Is the cellular response to cycloheximide conserved?
The core translation inhibition and eIF2alpha phosphorylation pathways are conserved in eukaryotes.
Conclusion
GO:0071409 cellular response to cycloheximide captures a fundamental biological process that links translation inhibition to stress signaling, gene expression, and cell-cycle control. Understanding this response is essential for interpreting experiments that use cycloheximide and for uncovering mechanisms of cellular adaptation to translational stress. With CRISPR-based models and multi-omics methods, researchers can now dissect the precise genes and pathways that mediate this response, with implications for cancer, aneuploidy, and other diseases.
References
- 1. Torres EM et al.. 2010. Thoughts on aneuploidy.. Cold Spring Harb Symp Quant Biol 75:445-51 PMID: 21289044
- 2. Yin Y et al.. 1999. Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress.. Mol Carcinog 24(1):15-24 PMID: 10029406
- 3. Repko EM et al.. 1989. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability.. J Biol Chem 264(17):9945-52 PMID: 2722887
- 4. Jiang HY et al.. 2003. Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses.. Mol Cell Biol 23(16):5651-63 PMID: 12897138
- 5. Copland JA et al.. 1987. Discrete early changes in cellular subpopulations of rat uterine and anterior pituitary estrogen receptors in response to acute exposure to exogenous estradiol.. J Steroid Biochem 26(6):723-31 PMID: 3613573
- 6. Dong Y et al.. 1989. The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response.. J Biol Chem 264(23):13679-83 PMID: 2547771
- 8. Kung AL et al.. 1993. Differences in the regulation of protein synthesis, cyclin B accumulation, and cellular growth in response to the inhibition of DNA synthesis in Chinese hamster ovary and HeLa S3 cells.. J Biol Chem 268(31):23072-80 PMID: 8226824
